ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,672Medicare Part D Prescriptions Filled, Including Refills

Rank: 479 out of 6969

$431K Total Retail Price of All Prescriptions

Rank: 810 out of 6969

448 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 448 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

10% of this provider’s 448 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 8,521 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LISINOPRIL 579 537 1 2
LEVOTHYROXINE SODIUM 502 422 2 5
AMLODIPINE BESYLATE 387 344 3 4
SIMVASTATIN 324 290 4 1
METFORMIN HCL 323 298 5 7
OMEPRAZOLE 276 224 6 6
PRAVASTATIN SODIUM 256 250 7 19
HYDROCHLOROTHIAZIDE 245 220 8 8
HYDROCODONE-ACETAMINOPHEN 218 142 S3 9 3
ZOLPIDEM TARTRATE 211 170 10 16
ALENDRONATE SODIUM 208 186 11 14
ATENOLOL 190 189 12 9
FUROSEMIDE 188 167 13 10
ATORVASTATIN CALCIUM 175 161 14 11
WARFARIN SODIUM 173 173 15 20
FLUOXETINE HCL 148 127 16 43
LOSARTAN POTASSIUM 137 133 17 12
LOVASTATIN 137 125 17 15
METOPROLOL TARTRATE 111 91 19 13
JANUVIA 106 100 20 41
CIPROFLOXACIN HCL 100 90 21 64
GEMFIBROZIL 100 69 21 85
PANTOPRAZOLE SODIUM 98 82 23 31
FENOFIBRATE 95 75 24 63
GLIPIZIDE 84 83 25 21
GABAPENTIN 84 56 25 17
DIOVAN 83 76 27 26
TRAMADOL HCL 78 51 28 27
POTASSIUM CHLORIDE 78 73 28 30
SERTRALINE HCL 77 76 30 38
IBUPROFEN 75 63 31 29
METOPROLOL SUCCINATE 75 75 31 22
GLIMEPIRIDE 74 64 33 44
ACTONEL 73 73 34 115
EVISTA 72 72 35 118
CITALOPRAM HBR 70 57 36 34
SPIRIVA 69 67 37 66
BENAZEPRIL HCL 68 68 38 18
ALLOPURINOL 64 52 39 35
TRICOR 64 59 39 143
AZITHROMYCIN 62 56 41 42
PROAIR HFA 54 34 42 33
DONEPEZIL HCL 50 50 43 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.